Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05106101 · ClinicalTrials.gov registry record · Phase 1
L-glutamine Treatment in Patients With Diverticulosis
A Phase 1 study of Diverticulosis, Colonic, sponsored by Emmaus Medical.
- Completed
- Registry status
- Phase 1
- Development phase
- 9
- Enrollment target
- 3
- Study locations
NCT05106101: Completed Phase 1 study of Diverticulosis, Colonic, sponsored by Emmaus Medical.
NCT05106101 is a Phase 1 study of Diverticulosis, Colonic that has completed, run by Emmaus Medical. The registered enrollment target is 9 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (85% lower). The trial reports 3 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05106101, a Phase 1 study of Diverticulosis, Colonic, has completed, sponsored by Emmaus Medical.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 9 participants
- Enrollment target
- 3
- Study locations
Study Summary
The purpose of the study is evaluate the safety and efficacy of L-glutamine as a treatment for patients with diverticulosis.
Primary Outcome
Number of diverticula for both the descending colon and sigmoid will be counted at baseline, at 6 months and at 12 months
Conditions Studied
Interventions
- DRUG L-glutamine
Study Locations (3)
California
- The Lundquist Institute at Harbor-UCLA Medical Center - Torrance
- Ventura Clinical Trials - Ventura
Texas
- Clinical Trials of Texas, Inc. - San Antonio
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2019-07-19 |
| Est. Completion | 2022-12-30 |
| Phase | Phase 1 |
What the finished NCT05106101 record still lists
NCT05106101 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (85% lower).
The record links to 1 condition, with Diverticulosis, Colonic appearing as the primary indexed condition, and to 1 intervention - of which L-glutamine is the first listed.
NCT05106101 reports a single indexed study location in California, Texas.
Frequently Asked Questions
What is clinical trial NCT05106101 about?
NCT05106101 is a clinical study titled "L-glutamine Treatment in Patients With Diverticulosis". The purpose of the study is evaluate the safety and efficacy of L-glutamine as a treatment for patients with diverticulosis.
What is the current status of trial NCT05106101?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 9 participants. The study started on 2019-07-19. Estimated completion is 2022-12-30.
What conditions does trial NCT05106101 study?
This clinical trial studies the following conditions: Diverticulosis, Colonic.
What interventions are being tested in trial NCT05106101?
The interventions under investigation include: L-glutamine (DRUG).
Who is sponsoring clinical trial NCT05106101?
This trial is sponsored by Emmaus Medical, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05106101 being conducted?
This trial has 3 study locations across California, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05106101's enrollment target sits among peer trials
9 1955th of 2000 higher than 42 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI